We are live on ! Find out more
HLA

Hamilton Lane Advisors Portfolio holdings

AUM $149M
1-Year Est. Return 14.17%
This Fund
S&P 500
This Quarter Est. Return
-2.96%
1 Year Est. Return
-14.17%
3 Year Est. Return
+186.76%
5 Year Est. Return
+98.42%
10 Year Est. Return
+778.69%
AUM
$239M
AUM Growth
+$37.2M
Cap. Flow
+$61M
Cap. Flow %
25.54%
Top 10 Hldgs %
79.81%
Holding
65
New
18
Increased
10
Reduced
14
Closed
13

Sector Composition

Rank Sector Weight
1 Technology 80.43%
2 Healthcare 8.6%
3 Communication Services 2.59%
4 Industrials 2.19%
5 Consumer Staples 2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PDD icon
26
Pinduoduo
PDD
$125B
$1.5M 0.63%
+46,412
New +$1.24M
FSCT
27
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
$1.21M 0.51%
31,912
-20,000
-39% -$731K
ZLAB icon
28
Zai Lab
ZLAB
$2.05B
$796K 0.33%
+24,593
New +$844K
RYTM icon
29
Rhythm Pharmaceuticals
RYTM
$6.91B
$750K 0.31%
34,736
RDFN
30
DELISTED
Redfin
RDFN
$744K 0.31%
44,184
+21,970
+99% +$387K
KURA icon
31
Kura Oncology
KURA
$795M
$591K 0.25%
38,948
+28,663
+279% +$510K
VCYT icon
32
Veracyte
VCYT
$3.54B
$591K 0.25%
+24,633
New +$655K
TRUP icon
33
Trupanion
TRUP
$1.06B
$581K 0.24%
22,849
-10,000
-30% -$293K
PI icon
34
Impinj
PI
$4.52B
$573K 0.24%
18,598
+10,008
+117% +$349K
NPTN
35
DELISTED
NEOPHOTONICS CORP
NPTN
$532K 0.22%
87,329
-56,896
-39% -$320K
FINV
36
FinVolution Group
FINV
$1.14B
$489K 0.2%
168,750
-282,096
-63% -$1.08M
NOAH
37
Noah Holdings
NOAH
$577M
$475K 0.2%
16,263
-10,000
-38% -$319K
DNLI icon
38
Denali Therapeutics
DNLI
$3.75B
$474K 0.2%
+30,948
New +$591K
GOOG icon
39
Alphabet (Google) Class C
GOOG
$4.27T
$338K 0.14%
+5,540
New +$328K
EVER icon
40
EverQuote
EVER
$865M
$308K 0.13%
+14,448
New +$273K
NSTG
41
DELISTED
NanoString Technologies, Inc.
NSTG
$297K 0.12%
13,740
-99,170
-88% -$2.63M
LX
42
LexinFintech Holdings
LX
$241M
$296K 0.12%
+29,485
New +$321K
MOMO
43
Hello Group
MOMO
$878M
$287K 0.12%
+9,275
New +$315K
INSP icon
44
Inspire Medical Systems
INSP
$1.42B
$243K 0.1%
3,984
-38,336
-91% -$2.52M
VIOT
45
Viomi Technology
VIOT
$50.9M
$210K 0.09%
25,726
-12,501
-33% -$109K
CTMX icon
46
CytomX Therapeutics
CTMX
$686M
$147K 0.06%
19,898
KALA icon
47
KALA BIO
KALA
$13M
$133K 0.06%
14
CLVS
48
DELISTED
Clovis Oncology, Inc.
CLVS
$55K 0.02%
13,929
MOGU
49
MOGU Inc
MOGU
$16.3M
$32K 0.01%
+1,073
New +$34.3K
FBRX icon
50
Forte Biosciences
FBRX
$1.57B
$13K 0.01%
53

Similar funds

Hamilton Lane Advisors's Q3 2019 Portfolio in Review

As of Q3 2019, Hamilton Lane Advisors held 65 positions worth $239M, up 18% from $202M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Hamilton Lane Advisors deployed $61M of net new capital in Q3 2019, opening 18 new positions and adding to 10 existing holdings. Its largest new stake was Verra Mobility: 7,608,696 shares worth $109M.

By sector, the portfolio is most concentrated in Technology at 80% of assets, down from 83% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was DocuSign, an estimated $46.3M trimmed.

  • Hamilton Lane Advisors's largest Q3 2019 buy was Verra Mobility: 7,608,696 shares worth $109M.
  • Hamilton Lane Advisors added most to Avalara, Inc. in Q3 2019, an estimated $7.36M increase.
  • Hamilton Lane Advisors's biggest Q3 2019 reduction was DocuSign, cutting an estimated $46.3M.
  • Hamilton Lane Advisors fully exited Alphabet (Google) Class A in Q3 2019, selling an estimated $5.75M.
  • Hamilton Lane Advisors's ten largest holdings make up 80% of its $239M portfolio in Q3 2019.
  • Hamilton Lane Advisors opened 18 new positions and closed 13 in Q3 2019.
  • Hamilton Lane Advisors's portfolio value rose 18% quarter-over-quarter to $239M.

Based on Hamilton Lane Advisors's 13F filing for Q3 2019, filed 13 Nov 2019.